Lin Shao-Lee insider trades
Lin Shao-Lee has filed 19 Form 4s with the SEC that we hold, for SLRN (Chief Executive Officer, Director), Cue Biopharma, Inc. (CUE) (Chief Executive Officer, Director), Surrozen, Inc./DE (SRZN) (Director) and THRD (Director). Across all of them we count 0 purchases worth $0 and 10 sales worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($1.9M). The largest single trade was a sale of 34,225 shares of Cue Biopharma, Inc. worth $923.7K, dated 2026-08-12. Of 2 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-06-09 and the latest 2026-10-14.
SLRN
Cue Biopharma, Inc. (CUE)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-08-12 | S, sale reported on Form 4 | 34,225 | $923.7K | 2026-08-14 | SEC |
| 2026-08-12 | S, sale reported on Form 4 | 5,775 | $160.3K | 2026-08-14 | SEC |
| 2026-08-13 | S, sale reported on Form 4 | 5,423 | $147.5K | 2026-08-14 | SEC |
| 2026-08-13 | S, sale reported on Form 4 | 2,375 | $66.8K | 2026-08-14 | SEC |
| 2026-08-13 | S, sale reported on Form 4 | 10,460 | $308.4K | 2026-08-14 | SEC |
| 2026-10-12 | S, sale reported on Form 4 | 10,000 | $275.0K | 2026-10-14 | SEC |
| 2026-10-12 | S, sale reported on Form 4 | 1,087 | $30.5K | 2026-10-14 | SEC |
Surrozen, Inc./DE (SRZN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
THRD
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1725092) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
